Nordic Nanovector To Restructure After Discontinuing Lymphoma Trial

 
• By Alaric DeArment
  
Nordic Nanovector plans to restructure after discontinuing its NHL trial, PARADIGME • Source: Shutterstock

More from Clinical Trials

More from R&D